Notice Concerning Revisions to the Financial Results Forecasts
Notice Concerning Revisions to the Financial Results Forecasts | IR News | News Release ＆ IR News | Investor Relations Read more
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the... Read more
MKS Instruments Reports Third Quarter 2023 Financial Results
Revenue of $932 million, in-line with the midpoint of guidance GAAP gross margin of 45.7% and Non-GAAP gross margin of 47.1%, above the high-end of guidance GAAP operating margin of 12.6% and Non-GAAP operating margin of 21.8%, above the high-end of guidance GAAP net income per diluted share of Read more
Xylem Reports Third Quarter 2023 Results
Revenue of $2.1 billion , up 50% on a reported basis, and 10% organically Earnings per share of $0.63 , up 800%; adjusted earnings per share of $0.99 , up 14% Raising full-year revenue guidance to approximately $7.3B , up 32% from 30%, with expected organic revenue growth of 11%, up from 9% to 10% Read more
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the... Read more